Live from the NIH registry
Studies recruiting near St. Paul right now
Top 25 of 1,092 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospitals and Clinics of Minnesota - Minneapolis — Minneapolis, Minnesota (8.1 mi)
· Sponsor: National Cancer Institute (NCI)
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Allina — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Dosentrx Ltd.
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
University of Minnesota Medical School — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Azafaros B.V.
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
The ED-AWARENESS-2 Trial
Awareness, Mechanical Ventilation
N/A
Interventional 3,090 participants sought
Hennepin Healthcare — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Washington University School of Medicine
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Minnesota Oncology Hematology, P.A. — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Relay Therapeutics, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
International Diabetes Center — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Neurotrophic Keratitis
Phase 2
Interventional 54 participants sought
Minnesota Eye Consultants — Minneapolis, Minnesota (8.1 mi)
· Sponsor: TearSolutions, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
VitreoRetinal Surgery, PLLC. — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Genentech, Inc.
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
DaVita Clinical Research Edina — Edina, Minnesota (12.7 mi)
· Sponsor: R1 Therapeutics
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Minneapolis, Minnesota (8.1 mi)
· Sponsor: AstraZeneca
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0073 — Saint Paul, Minnesota (0.6 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Regions Hospital — Saint Paul, Minnesota (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Jaeb Center for Health Research
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
M Health Fairview St. John's Hospital — Maplewood, Minnesota (5.3 mi)
· Sponsor: Joseph Broderick, MD
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
MNGI Digestive Health, PA — Plymouth, Minnesota (17.7 mi)
· Sponsor: Takeda
Exploration of the Utility of Dental-dedicated MRI for Dentistry
Dental Crowding, Dental Occlusion, Traumatic
N/A
Observational 300 participants sought
Orofacial MRI Center at UMN — Minneapolis, Minnesota (8.1 mi)
· Sponsor: University of Minnesota
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Metro-Minnesota Community Clinical Oncology ( Site 0144) — Saint Louis Park, Minnesota (11.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Carotid Artery Calcification, Carotid Artery Diseases
N/A
Interventional 185 participants sought
Allina Health Minneapolis Heart Institute — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Shockwave Medical, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Regions Hospital — Saint Paul, Minnesota (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices
Fusion of Spine, Sacroiliac; Fusion
N/A
Interventional 500 participants sought
Nura Precision Pain Management — Edina, Minnesota (12.7 mi)
· Sponsor: Spinal Simplicity LLC
PASCAL Feasibility Study
Smoking Cessation, Smoking (Tobacco) Addiction
N/A
Interventional 120 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: University of Minnesota
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Children's Minnesota — Saint Paul, Minnesota (0.6 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1
Interventional 36 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: PeproMene Bio, Inc.